Loading
Latest filing published 31 Aug 2026 for Theralase Technologies Inc., €668. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Randall Bruder on record concern Theralase Technologies Inc. Over a trading history stretching from 24 August 2016 to 31 August 2026, the count stands at 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €554, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 31 August 2026, reports an option exercise of €668 in Theralase Technologies Inc. The most recent open-market purchase was published on 31 August 2026, 48 days ago. Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations